Citation Impact
Citing Papers
Ambrisentan for the Treatment of Pulmonary Arterial Hypertension
2008 Standout
Predicting Survival in Pulmonary Arterial Hypertension
2010 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
The gut microbiota and host health: a new clinical frontier
2015 Standout
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
2009
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Treatment of established postoperative nausea and vomiting: a quantitative systematic review
2001
Anaesthesia, surgery, and challenges in postoperative recovery
2003 Standout
Certolizumab pegol in rheumatoid arthritis patients with low to moderate activity: the CERTAIN double-blind, randomised, placebo-controlled trial
2014
Satb1 regulates the effector program of encephalitogenic tissue Th17 cells in chronic inflammation
2019 StandoutNobel
Tadalafil Therapy for Pulmonary Arterial Hypertension
2009 Standout
A meta-analysis of trials of pulmonary hypertension: A clinical condition looking for drugs and research methodology
2007
AGA technical review on nausea and vomiting
2001
Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis
2014
Idiopathic pulmonary fibrosis
2017 Standout
Comparative Efficacy and Safety of Ondansetron, Droperidol, and Metoclopramide for Preventing Postoperative Nausea and Vomiting
1999
Medical Therapy For Pulmonary Arterial Hypertension
2004
Targeting Interleukin-6 Signaling in Clinic
2019
The effectiveness of rescue antiemetics after failure of prophylaxis with ondansetron or droperidol: a preliminary report
2005
Functional Gastroduodenal Disorders
2006 Standout
Rheumatoid arthritis
2016 Standout
Medical Therapy for Pulmonary Arterial Hypertension
2007
Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer
2015
Treatment of Pulmonary Arterial Hypertension
2004 Standout
Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
2011 Standout
Pulmonary Arterial Hypertension
2009
Effects of oral treatments on exercise capacity in systemic sclerosis related pulmonary arterial hypertension: a meta-analysis of randomised controlled trials
2007
A Factorial Trial of Six Interventions for the Prevention of Postoperative Nausea and Vomiting
2004 Standout
Definitions and Diagnosis of Pulmonary Hypertension
2013 Standout
Exercise Standards for Testing and Training
2013 Standout
The 6-min walk test (6MW) as an efficacy endpoint in pulmonary arterial hypertension clinical trials: Demonstration of a ceiling effect
2005
Consensus Guidelines for Managing Postoperative Nausea and Vomiting
2003 Standout
Prevention of postoperative nausea and vomiting by metoclopramide combined with dexamethasone: randomised double blind multicentre trial
2006
Updated Clinical Classification of Pulmonary Hypertension
2009 Standout
Low-dose droperidol (≤1 mg or ≤15 μg kg−1) for the prevention of postoperative nausea and vomiting in adults
2012
Addition of Inhaled Treprostinil to Oral Therapy for Pulmonary Arterial Hypertension
2010
Pulmonary Arterial Hypertension
2006
Creation of a Model Comparing 6-Minute Walk Test to Metabolic Equivalent in Evaluating Treatment Effects in Pulmonary Arterial Hypertension
2007
Incidence and clinical relevance of supraventricular tachyarrhythmias in pulmonary hypertension
2006
Ondansetron Orally Disintegrating Tablet Versus Placebo for the Prevention of Postdischarge Nausea and Vomiting After Ambulatory Surgery
2002
No clinically relevant pharmacokinetic and safety interactions of ambrisentan in combination with tadalafil in healthy volunteers
2009
Management of Pulmonary Arterial Hypertension Associated with Congenital Systemic-to-Pulmonary Shunts and Eisenmenger???s Syndrome
2008
IL-6 as a keystone cytokine in health and disease
2015 Standout
Pulmonary Hypertension in Patients With Idiopathic Pulmonary Fibrosis
2005
Society for Ambulatory Anesthesia Guidelines for the Management of Postoperative Nausea and Vomiting
2007
Treatment of Pulmonary Arterial Hypertension With the Selective Endothelin-A Receptor Antagonist Sitaxsentan
2006
Air Pollution and Heart Rate Variability
2008
Small-Dose Droperidol Effectively Reduces Nausea in a General Surgical Adult Patient Population
2000
Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges
2015
The Functional Gastrointestinal Disorders and the Rome III Process
2006 Standout
Congenital Heart Disease Associated Pulmonary Arterial Hypertension
2007
Bladder cancer
2016 Standout
Cardiopulmonary exercise testing in patients with pulmonary arterial hypertension: An evidence-based review
2009
Consensus Guidelines for the Management of Postoperative Nausea and Vomiting
2013 Standout
Haloperidol Plus Ondansetron Versus Ondansetron Alone for Prophylaxis of Postoperative Nausea and Vomiting
2008
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
Clinician’s Guide to Cardiopulmonary Exercise Testing in Adults
2010 Standout
Effects of Iron Supplementation and Depletion on Hypoxic Pulmonary Hypertension
2009 StandoutNobel
Sickle-cell disease
2010 Standout
Hemodynamic and Functional Assessment of Patients with Sickle Cell Disease and Pulmonary Hypertension
2007
Progress report on new antiepileptic drugs: a summary of the Fifth Eilat Conference (EILAT V)
2001
Ambrisentan Therapy for Pulmonary Arterial Hypertension
2005
A meta-analysis of randomized controlled trials in pulmonary arterial hypertension
2008
Efficacy, dose-response, and adverse effects of droperidol for prevention of postoperative nausea and vomiting
2000
Synergistic neuroprotective therapies with hypothermia
2010
Haloperidol vs. ondansetron for the prevention of postoperative nausea and vomiting following gynaecological surgery
2006
Cardiopulmonary exercise testing in the assessment of pulmonary hypertension
2011
Profilaxia antiemética em cirurgia de abdome agudo: estudo comparativo entre droperidol, metoclopramida, tropisetron, granisetron e dexametasona
2008
Exercise Testing and Training in Chronic Lung Disease and Pulmonary Arterial Hypertension
2011
Supplemental oxygen does not reduce postoperative nausea and vomiting after thyroidectomy † †Presented in part at the annual meeting of the American Society of Anesthesiologists, New Orleans, October 13–17, 2001.
2003
A Randomized, Double-Blinded Comparison of Ondansetron, Droperidol, and Placebo for Prevention of Postoperative Nausea and Vomiting After Supratentorial Craniotomy
2000
Efficacy, safety, and adherence with a twice-daily combination lamivudine/zidovudine tablet formulation, plus a protease inhibitor, in HIV infection
2000
Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial
2008
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension
2015 Standout
A Comparison of Ondansetron with Promethazine for Treating Postoperative Nausea and Vomiting in Patients Who Received Prophylaxis with Ondansetron: A Retrospective Database Analysis
2007
Combination therapy for postoperative nausea and vomiting — a more effective prophylaxis?
2001
Does Supplemental Oxygen Reduce Postoperative Nausea and Vomiting? A Meta-Analysis of Randomized Controlled Trials
2008
Idiopathic pulmonary fibrosis
2011 Standout
Sildenafil therapy in patients with sickle cell disease and pulmonary hypertension
2005
Impact of Antiemetic Selection on Postoperative Nausea and Vomiting and Patient Satisfaction
2001
The increase in pulmonary arterial pressure caused by hypoxia depends on iron status
2008 StandoutNobel
Postoperative Nausea and Vomiting—Can It Be Eliminated?
2002
Serial Development of Pulmonary Hypertension in Patients with Idiopathic Pulmonary Fibrosis
2008
Prevention and Treatment of Postoperative Nausea and Vomiting
2000
Pharmacological Prophylaxis and Management of Adult Postoperative/Postdischarge Nausea and Vomiting
2006
Guidelines for the Echocardiographic Assessment of the Right Heart in Adults: A Report from the American Society of Echocardiography
2010 Standout
Complications of Right Heart Catheterization Procedures in Patients With Pulmonary Hypertension in Experienced Centers
2006
Macitentan for the treatment of idiopathic pulmonary fibrosis: the randomised controlled MUSIC trial
2013
Clinical Course and Prediction of Survival in Idiopathic Pulmonary Fibrosis
2010 Standout
Pulmonary Arterial Hypertension in France
2006 Standout
Comparative Efficacy and Safety of Ondansetron, Droperidol, and Metoclopramide for Preventing Postoperative Nausea and Vomiting
1999
Effect of Low-dose Droperidol on the QT Interval during and after General Anesthesia
2005
A rational approach to the control of postoperative nausea and vomiting: evidence from systematic reviews. Part I. Efficacy and harm of antiemetic interventions, and methodological issues
2001
Diversity‐Oriented Syntheses by Combining CuAAC and Stereoselective INCIC Reactions with Peptides
2017 StandoutNobel
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease
2008 Standout
Pulmonary Arterial Hypertension
2006
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Cooling for newborns with hypoxic ischaemic encephalopathy
2013 Standout
Indications for Cardiac Catheterization and Intervention in Pediatric Cardiac Disease
2011 Standout
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Cytokine Storm
2020 Standout
Warfarin plus Aspirin after Myocardial Infarction or the Acute Coronary Syndrome: Meta-Analysis with Estimates of Risk and Benefit
2005
Pharmacological Basis for Concentration-Controlled Therapy with Zidovudine, Lamivudine, and Indinavir
2001
Interventions for enhancing medication adherence
2014 Standout
Chronic Thromboembolic Pulmonary Hypertension
2006 Standout
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Right Ventricular Function in Cardiovascular Disease, Part I
2008 Standout
Particulate Matter Air Pollution and Cardiovascular Disease
2010 Standout
Evaluation and Management of the Patient with Pulmonary Arterial Hypertension
2005
Pathobiology of Pulmonary Hypertension
2007
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
2009 Standout
Therapeutic antibodies that target inflammatory cytokines in autoimmune diseases
2015
Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms?
2012 Standout
Works of Benjamin Duncan being referenced
Efficacy and Safety of Certolizumab Pegol in a Broad Population of Patients with Active Rheumatoid Arthritis: Week 28 Results From a Phase IIIb Randomized Controlled Study
2011
Adjunctive levetiracetam in infants and young children with refractory partial‐onset seizures
2009
Lamivudine/Zidovudine as a Combined Formulation Tablet: Bioequivalence Compared with Lamivudine and Zidovudine Administered Concurrently and the Effect of Food on Absorption
1999
A Comparison of the Efficacy, Safety, and Patient Satisfaction of Ondansetron Versus Droperidol as Antiemetics for Elective Outpatient Surgical Procedures
1998
Efficacy and safety of certolizumab pegol in a broad population of patients with active rheumatoid arthritis: results from the REALISTIC phase IIIb study
2012
Efficacy and safety of olokizumab in patients with rheumatoid arthritis with an inadequate response to TNF inhibitor therapy: outcomes of a randomised Phase IIb study
2014
Pharmacokinetics of Lamotrigine in Children in the Absence of other Antiepileptic Drugs
1999
Sitaxsentan Therapy for Pulmonary Arterial Hypertension
2003
A Comparison of the Efficacy, Safety, and Patient Satisfaction of Ondansetron Versus Droperidol as Antiemetics for Elective Outpatient Surgical Procedures
1998